Lorazepam Tablet
Product Images NDC 71610-600

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 71610-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2 mg (71610 0600 30)

Bottle Label 2 mg (71610 0600 30)
Label for Lorazepam USP 2 mg oral tablets, containing 30 tablets per bottle. The label includes the NDC 71610-0600-30 and storage instructions to keep between 20-25 degrees Celsius. Manufacturer is Aurobindo Pharma, LLC in Dayton, NJ, and repackager is Aphena Pharma Solutions in Cookeville, TN. The label warns to keep out of reach of children and notes the drug is prescription-only (C-IV controlled substance).*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical-structure (Lorazepam Str)

Chemical-structure (Lorazepam Str)
Chemical structure of lorazepam showing its molecular formula (C15H10Cl2N2O2) and molecular weight (321.16). The diagram depicts the arrangement of atoms including chlorine (Cl), nitrogen (N), oxygen (O), and hydrogen (H) in the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.